Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sufficiently important difference for common cold: severity reduction.

Bruce Barrett1, Brian Harahan, David Brown

  • 1Department of Family Medicine, University of Wisconsin, Madison, Wisc 53715, USA. bruce.barrett@fammed.wisc.edu

Annals of Family Medicine
|June 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasal steroids, irrigation, oral antibiotics, and subgroup targeting for effective management of acute sinusitis (NOSES): Protocol for a comparative effectiveness randomized controlled trial.

PloS one·2026
Same author

Symptoms Associated With Detection of Viral Versus Bacterial Pathogens in Outpatients With Lower Respiratory Infections.

Influenza and other respiratory viruses·2026
Same author

Catastrophizing contributes to the association between posttraumatic stress symptoms and pain outcomes in individuals with chronic low back pain: Differential effects as a function of sex.

The journal of pain·2026
Same author

External validation of risk scores and multivariate models for the diagnosis of community-acquired pneumonia in outpatients.

The European journal of general practice·2026
Same author

Autonomic indices of negative emotion regulation predict treatment response in opioid-treated chronic low back pain.

The journal of pain·2026
Same author

Demographics in distress: a national study of burnout and well-being of resident physicians in high-burnout specialties.

BMC medical education·2026
Same journal

Advancing Family Medicine Through Dyadic Electronic Medical Record Linkage in Dementia Care.

Annals of family medicine·2026
Same journal

Association of General Practice Continuity With Hospital Admissions and Costs: A Retrospective Study.

Annals of family medicine·2026
Same journal

Association of Advanced Access With Primary Care Performance: A Systematic Review.

Annals of family medicine·2026
Same journal

Death by Rousui in Japan: Rethinking Death, Diagnosis, and Care in an Aging Society.

Annals of family medicine·2026
Same journal

Navigating Changing Waters, Staying Anchored in Our Values at the 2026 ADFM Annual Conference.

Annals of family medicine·2026
Same journal

Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care.

Annals of family medicine·2026
See all related articles

Patients desire a 25% to 57% reduction in common cold severity to justify treatment costs and risks. Current scientific evidence does not support benefits this large for popular cold remedies.

Area of Science:

  • Health Economics
  • Patient-Reported Outcomes
  • Clinical Trial Design

Background:

  • The common cold is a widespread illness with significant economic impact.
  • Quantifying the minimum acceptable benefit for treatments is crucial for cost-effectiveness analysis.
  • Existing research often lacks patient perspectives on treatment value.

Purpose of the Study:

  • To estimate the Sufficiently Important Difference (SID) for common cold treatments.
  • To determine the smallest benefit justifying the costs and risks of interventions.
  • To compare patient-perceived value across different cold remedies.

Main Methods:

  • Benefit-harm tradeoff interviews were conducted with participants.
  • Evidence-based scenarios were used to assess SID for vitamin C, echinacea, zinc lozenges, and pleconaril.

Related Experiment Videos

  • Data from in-person and telephone interviews were analyzed and merged.

    • Main Results:

    • Mean SID varied by treatment, ranging from 25% for vitamin C to 57% for pleconaril.
    • Illness severity, age, sex, and socioeconomic factors did not predict SID.
    • Individual SID values showed considerable diversity across participants and treatments.

    Conclusions:

    • Patients require substantial symptom reduction (25%-57%) to deem cold treatments worthwhile.
    • Current randomized trial evidence for common cold treatments does not meet these patient-defined benefit thresholds.
    • The SID model offers a framework for evaluating other medical interventions based on patient preferences.